I. W. Fong

4.8k total citations
99 papers, 3.5k citations indexed

About

I. W. Fong is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, I. W. Fong has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 27 papers in Infectious Diseases and 27 papers in Microbiology. Recurrent topics in I. W. Fong's work include Reproductive tract infections research (21 papers), Antifungal resistance and susceptibility (13 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). I. W. Fong is often cited by papers focused on Reproductive tract infections research (21 papers), Antifungal resistance and susceptibility (13 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). I. W. Fong collaborates with scholars based in Canada, United States and United Kingdom. I. W. Fong's co-authors include B Chiu, William Tucker, James B. Mahony, Michael Fong, Emil Toma, Mark Loeb, Brian Chiu, Tai‐Wai Chin, Lee Errett and Ana Konvalinka and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

I. W. Fong

98 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. W. Fong Canada 31 1.6k 1.0k 659 554 377 99 3.5k
H. J. Koornhof South Africa 33 1.7k 1.1× 1.2k 1.1× 492 0.7× 312 0.6× 310 0.8× 93 3.2k
P.J. van den Broek Netherlands 35 1.4k 0.9× 598 0.6× 313 0.5× 340 0.6× 262 0.7× 108 3.4k
R. Russell Martin United States 36 2.5k 1.6× 1.2k 1.2× 554 0.8× 717 1.3× 685 1.8× 128 5.2k
Richard F. Jacobs United States 39 3.3k 2.1× 2.3k 2.2× 363 0.6× 549 1.0× 426 1.1× 136 5.4k
Melvin I. Marks United States 37 1.8k 1.1× 1.1k 1.1× 448 0.7× 395 0.7× 628 1.7× 194 4.2k
Itamar Shalit Israel 31 943 0.6× 867 0.8× 541 0.8× 186 0.3× 543 1.4× 82 3.4k
Aldona L. Baltch United States 29 1.3k 0.9× 1.1k 1.0× 230 0.3× 215 0.4× 357 0.9× 115 2.9k
A. William Pasculle United States 38 1.9k 1.2× 2.2k 2.2× 268 0.4× 480 0.9× 596 1.6× 113 5.3k
Mitsuo Kaku Japan 40 2.0k 1.3× 1.8k 1.7× 516 0.8× 328 0.6× 428 1.1× 333 5.7k
Gary J. Noel United States 32 1.1k 0.7× 1.2k 1.2× 253 0.4× 206 0.4× 756 2.0× 88 3.2k

Countries citing papers authored by I. W. Fong

Since Specialization
Citations

This map shows the geographic impact of I. W. Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. W. Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. W. Fong more than expected).

Fields of papers citing papers by I. W. Fong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. W. Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. W. Fong. The network helps show where I. W. Fong may publish in the future.

Co-authorship network of co-authors of I. W. Fong

This figure shows the co-authorship network connecting the top 25 collaborators of I. W. Fong. A scholar is included among the top collaborators of I. W. Fong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. W. Fong. I. W. Fong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoong, Deborah, et al.. (2017). Dolutegravir and metformin. AIDS. 31(15). 2176–2177. 5 indexed citations
3.
Loutfy, Mona, John W. Austin, B. Blanchfield, & I. W. Fong. (2003). An Outbreak of Foodborne Botulism in Ontario. Canadian Journal of Infectious Diseases and Medical Microbiology. 14(4). 206–209. 10 indexed citations
4.
Fong, I. W., et al.. (2002). Chlamydial Heat‐Shock Protein–60 Antibody and Correlation withChlamydia pneumoniaein Atherosclerotic Plaques. The Journal of Infectious Diseases. 186(10). 1469–1473. 26 indexed citations
5.
Fong, I. W.. (2002). Infections and their role in atherosclerotic vascular disease. The Journal of the American Dental Association. 133. 7S–13S. 29 indexed citations
6.
Fong, I. W., et al.. (2000). Transfusion-transmitted babesiosis in Ontario: first reported case in Canada.. PubMed. 26(2). 9–13. 10 indexed citations
7.
Shafran, Stephen D., James Talbot, Joel Singer, et al.. (1998). Does In Vitro Susceptibility to Rifabutin and Ethambutol Predict the Response to Treatment of Mycobacterium avium Complex Bacteremia with Rifabutin, Ethambutol, and Clarithromycin?. Clinical Infectious Diseases. 27(6). 1401–1405. 16 indexed citations
8.
Phillips, Elizabeth J., C. A. Ottaway, John Freedman, et al.. (1997). The Effect of Exercise on Lymphocyte Redistribution and Leucocyte Function in Asymptomatic HIV-Infected Subjects. Brain Behavior and Immunity. 11(3). 217–227. 9 indexed citations
9.
Phillips, Peter, Stephen Shafran, Gary Garber, et al.. (1997). Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(5). 337–345. 172 indexed citations
10.
Fong, I. W., Carolyn B. Britton, K. Luinstra, Emil Toma, & James B. Mahony. (1995). Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Journal of Clinical Microbiology. 33(2). 484–486. 88 indexed citations
11.
Fong, I. W., et al.. (1994). Alcoholism and Rapid Progression to AIDS After Seroconversion. Clinical Infectious Diseases. 19(2). 337–338. 33 indexed citations
12.
Chow, Pierce K. H., et al.. (1993). Medication use patterns in HIV-positive patients.. PubMed. 46(4). 171–5. 29 indexed citations
13.
Fong, I. W., et al.. (1992). Case Report: I reatment of Blastomycosis with Fluconazole. The American Journal of the Medical Sciences. 303(5). 313–315. 20 indexed citations
14.
Fong, I. W., et al.. (1992). Splenic Abscess Caused by Blastomyces dermatitidis in Association with Peritoneal Involvement: Case Report and Review. Clinical Infectious Diseases. 14(1). 348–349. 4 indexed citations
16.
Fong, I. W., et al.. (1991). Bacterial Meningitis in HIV‐Infected Patients: Case Reports and Review of the Literature. Canadian Journal of Infectious Diseases and Medical Microbiology. 3(2). 71–74.
17.
Jindal, Kailash, et al.. (1991). Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney International. 40(5). 934–938. 144 indexed citations
18.
Fong, I. W., et al.. (1990). Pharmacokinetics of Fluconazole in Serum and Cerebrospinal Fluid in a Patient with AIDS and Cryptococcal Meningitis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(4). 305–307. 29 indexed citations
19.
Fong, I. W.. (1983). Staphylococcal central nervous system infections treated with cloxacillin. Journal of Antimicrobial Chemotherapy. 12(6). 607–612. 9 indexed citations
20.
Fong, I. W., et al.. (1981). Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study. Journal of Antimicrobial Chemotherapy. 7(1). 81–88. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026